Document is current
Any future updates will be listed below
-
Authors
Kanda, Yoshinobu
Takenaka, Katsuto
Tanabe, Tatsu
Omoto, Kazuya
Kamimura, Kei https://orcid.org/0009-0003-5672-186X
Kudou, Kentaro
Kaneko, Masato
-
Funding
Funding for this research was provided by:
Takeda Pharmaceutical Company
- License Information
-
More Information
Article History
Received: 29 September 2025
Revised: 22 April 2026
Accepted: 22 April 2026
First Online: 12 June 2026
Declarations
:
: KKa, KKu, and MK are employees of Takeda Pharmaceutical Company Limited, Osaka, Japan and hold stock and/or stock options from Takeda. YK reports relationships with Mitsubishi Tanabe Pharma Corporation, Viatris, and Clinigen, and lecture fees from MSD. YK is an Associate Editor of the International Journal of Hematology. KT, TT, and KO declare that they have no conflicts of interest.
